Back
Science

Colorectal Cancer Genetic Risk Communication Study Launched by Alliance for Clinical Trials

Generated on: Last updated: 1 sources
View source

Family Communications After Genetic Testing: A New Clinical Study

The Alliance for Clinical Trials in Oncology has launched a new clinical study titled "Family Communications After Genetic Testing." This trial aims to improve how colorectal cancer patients communicate genetic risk information to their family members. Supported by National Cancer Institute grants, the study plans to enroll approximately 4,000 colorectal cancer patients and their at-risk relatives across the United States.

Understanding Genetic Risk in Colorectal Cancer

About 30% of colorectal cancer cases are linked to genetics, and approximately 15% of newly diagnosed patients have a gene change (pathogenic germline variant) that increases cancer risk. When an inherited gene change is identified in one family member, close relatives, including parents, children, and siblings, may also carry the same gene. Awareness of this can lead to earlier screening, preventive actions, and timely cancer detection. Many relatives often do not receive this important information.

"The study aims to enhance communication between patients and families regarding cancer's genetic risks, hoping to facilitate early detection or prevention of colorectal cancers when they are more treatable." - Heather Hampel, M.S., CGC, Study Co-Chair and Genetic Researcher at City of Hope.

Comparing Communication Approaches

This trial will compare two methods of sharing genetic test results with a patient's close relatives:

  • Method 1: Proband-Mediated Communication - The patient personally shares the information with relatives.
  • Method 2: Provider-Mediated Communication - A healthcare provider directly contacts family members to explain genetic findings and recommend testing.

The primary objective is to determine which method leads to more family members receiving necessary genetic testing.

Key Research Questions

The study seeks to ascertain:

  • Genetic Testing Completion: The number of first-degree relatives (parents, children, siblings) who complete genetic testing using each approach.
  • Protective Health Measures: Whether relatives who discover they carry a gene change undertake protective health measures (e.g., increased screening like colonoscopies or at-home testing) within 12 months.
  • Demographic Impact: How communication approaches function across diverse demographic groups, including varying ages, ethnicities, or rural/urban residences.

Who Can Participate?

Participation in the trial is open to individuals diagnosed with colorectal cancer, stages I to IV, within the previous three months.

"Sharing genetic information can be challenging for patients, especially post-diagnosis. The study intends to identify a clear, effective approach to help families understand their risks and take preventive action." - Frank Sinicrope, MD, Study Co-Chair and Gastroenterologist at Mayo Clinic.